Skip to main content
Market snapshot: . Prices may have changed since this snapshot.
Events
GroupKALSHI
When will Compass Pathways submit a NDA for COMP360 psilocybin?
When will Compass Pathways submit a NDA for COMP360 psilocybin?
Reported volume
K 17.8K contracts
Events
1
Markets
3

Current odds

Snapshot from

As of Nov 22, 2026, 3:00 PM UTC, the highest-priced outcome on Kalshi is before April 2027 at 98.5%.

Kalshi

  1. before April 202798.5%
  2. before 202798%
  3. before December96%

Yes prices. They are not order quotes; check each platform's rules, fees and live prices before trading.

AI Analysis

Trader mode: Market mechanics, assumptions and risks

K 17.8K contracts

Reported volume · provider units

3

Saved contracts

0

Same-question pairs

Source snapshot: Nov 22, 2026, 3:00 PM UTC

This analysis was written from an earlier market snapshot, so its prices may be older than the odds above.

Snapshot observed Nov 11, 2026, 3:00 PM UTC. This analysis describes that snapshot and is not a live news update.

What the contract measures

The Kalshi event asks when COMPASS Pathways plc will submit a new drug application (NDA) for COMP360 psilocybin to the FDA. The source rule states: "If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before X 1, 2027, then the market resolves to Yes." [1] The rule text includes an early close condition: "This market will close and expire early if the event occurs." [1] The provider lists the event as active, with no listed end time supplied. [1]

The saved event contains three markets with different deadlines. Each has its own Yes and No prices and its own listed end date: December 2026 (listed end Dec 8, 2026, 3:00 PM UTC), before 2027 (Jan 8, 2027, 3:00 PM UTC), and before April 2027 (Apr 8, 2027, 2:00 PM UTC). [1] The listed end dates are contract metadata, not announced events. The rule text's "X 1, 2027" wording does not clearly match these three titles, so readers should check each market's own wording before comparing them.

Reading the snapshot

The prices were observed at Nov 11, 2026, 3:00 PM UTC and retrieved at Nov 11, 2026, 4:38 PM UTC. [1] They describe that window only and should not be read as live quotes. The Yes prices were 0.96 for the December deadline, 0.965 for the before-2027 deadline, and 0.975 for the before-April-2027 deadline. The matching No prices were 0.04, 0.035, and 0.025. [1]

Because the deadlines are nested, the later windows have higher Yes prices in this snapshot. These are quoted prices, not verified probabilities or executable trades. The snapshot does not show trading volume in a form that indicates liquidity or the number of participants, and it does not explain why any price is where it is.

All three saved markets are included, and the sample is not marked partial. [1] The source also notes that this does not establish that the provider lists every possible outcome. [1] Because these are different deadlines on one event, there is no single combined figure to report.

What remains uncertain

The evidence does not show any news about the NDA timeline, any statement from the company or regulator, or any reason for the observed prices. It also does not establish whether the saved snapshot still matches live market conditions. Any difference in price between these contracts reflects only the saved quotes and their wording, not a trading opportunity.

References

  1. Kalshi: When will Compass Pathways submit a NDA for COMP360 psilocybin?. Provider data observed Nov 11, 2026, 3:00 PM UTC.

AI-generated analysis based on market data. Not financial advice.

Saved Nov 11, 2026 UTC

This article was written from an earlier market snapshot and may be out of date. Use the dated market data and provider rules above for current information.

Overview

This PredictPedia entry covers a Kalshi contract asking when COMPASS Pathways plc will submit a new drug application (NDA) for COMP360 psilocybin to the FDA [1]. The contract's stated rule is that if COMPASS Pathways plc submits the NDA to the FDA before the date named in each market, the market resolves to Yes [1]. The source lists an early close condition: the market closes and expires early if the event occurs [1]. The saved provider event contains three markets with different cutoffs. One asks about a submission before December, one asks about a submission before 2027, and one asks about a submission before April 2027 [1]. The saved end dates for these markets are December 8, 2026, January 8, 2027, and April 8, 2027. The provider's listed end time for the event was not supplied in the source [1]. Because these are separate markets with different cutoffs, their results can differ depending on whether a submission happens before each deadline. The event was listed as active when the source was retrieved [1]. The prices attached to these markets are snapshots taken at the observation time. They are not executable quotes and should not be read as verified probabilities of a submission.

Why It Matters

The contract measures a single defined event: whether COMPASS Pathways plc submits an NDA for COMP360 psilocybin to the FDA before a specified cutoff [1]. Under the stated rule, a submission before a cutoff resolves that market to Yes, and the early close condition ends trading once the event occurs [1]. Traders following the contract therefore watch for a formal NDA submission, not for related regulatory discussions or announcements, because the rule is written around the submission itself [1]. The source does not describe how a submission would be publicly confirmed, so readers should check the contract rules directly for resolution details.

Snapshot context

The latest published provider snapshot for this topic was observed on 2026-11-11 at 15:00 UTC. It contains listings from Kalshi. Market descriptions and listed closing times define the contracts; they do not establish that the real-world outcome has occurred. This article does not include a separately verified news update. [1]

Frequently Asked Questions

What event makes the contract resolve Yes?

The market resolves to Yes if COMPASS Pathways plc submits a new drug application for COMP360 psilocybin to the FDA before the cutoff named in the specific market [1].

What happens after the event occurs?

The contract includes an early close condition, so the market closes and expires early if the event occurs [1].

Are the three markets the same contract?

They share one event, but each market uses a different cutoff: December, 2027 in general, and April 2027 [1]. Their prices should be compared only within the context of their own deadlines.

Was this helpful?
Saved Nov 11, 2026 UTC

AI-written background. References identify the evidence used; Wikipedia links under Learn More are additional reading. Prices and provider rules are dated snapshots. This is not financial advice.

Prices are catalog snapshots and may have changed. Check each market's rules and observation time.

KalshiHealth
When will the FDA approve Compass Pathways' COMP360 Psilocybin?

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

K 28.1K contracts
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)Yes 90.5%
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)Yes 88%
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)Yes 83.5%
+2 moreNext deadline Jan 1, 2027 UTC
KalshiHealth
When will Beam Therapeutics submit a BLA for Risto-cel?

When will Beam Therapeutics submit a BLA for Risto-cel?

K 11.2K contracts
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? (before April 2027)Yes 83.5%
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? (before 2027)Yes 45%
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? (before December)Yes 8%
3 mktsNext deadline Dec 1, 2026 UTC
PolymarketKalshiPolitics
Will the U.S. confirm that aliens exist?

Will the U.S. confirm that aliens exist?

PM $79.85M · K 35.90M contracts

Will the US confirm that aliens exist before 2027?

Kalshi: Will the U.S. confirm that aliens exist before 2027?

Same question, fine print differs

PM Yes 1.8%Rules differK Yes 1.8%

Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.

Saved prices; check contract rules.

1 saved comparisonNext deadline Dec 1, 2026 UTC
PolymarketKalshiTech
Best LLM at the end of the decade?

Best LLM at the end of the decade?

PM $8.74M · K 21.57M contracts

Will Google have the best AI model at the end of November 2026?

Kalshi: Best AI this week (Gemini)

Related contracts

PM Yes 97.8%Rules differK Yes 99.5%

Will Google have the best AI model at the end of November 2026?

Kalshi: Best LLM at the end of the decade? (Google)

Related contracts

PM Yes 97.8%Rules differK Yes 13%

Will Google have the best AI model at the end of November 2026?

Kalshi: Which AI companies will have a Pareto efficient model at the end of 2026? (Google)

Related contracts

PM Yes 97.8%Rules differK Yes 43.5%

Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.

Saved prices; check contract rules.

519 saved comparisonsNext deadline Nov 23, 2026 UTC
PolymarketKalshiHealth
Next pandemic

Next pandemic

PM $21.80M · K 1.16M contracts

Hantavirus pandemic in 2026?

Kalshi: Pandemic by Dec 31, 2027?

Related contracts

PM Yes 1.4%Rules differK Yes 17%

New pandemic in 2026?

Kalshi: Pandemic by Dec 31, 2027?

Related contracts

PM Yes 1.5%Rules differK Yes 17%

New Coronavirus Pandemic in 2026?

Kalshi: Pandemic in 2026?

Related contracts

PM Yes 1.6%Rules differK Yes 1.5%

Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.

Saved prices; check contract rules.

9 saved comparisonsNext deadline Jan 1, 2027 UTC
PolymarketKalshiClimate
Measles cases in U.S. in 2026?

Measles cases in U.S. in 2026?

PM $8.44M · K 765.8K contracts

Will there be at least 6000 measles cases in the U.S. in 2026?

Kalshi: Will there be more than 6000 measles cases in 2026?

Related contracts

PM Yes 99.7%Rules differK Yes 99%

Will there be at least 7000 measles cases in the U.S. in 2026?

Kalshi: Will there be more than 7000 measles cases in 2026?

Related contracts

PM Yes 91%Rules differK Yes 94.5%

Will there be at least 10000 measles cases in the U.S. in 2026?

Kalshi: Will there be more than 10000 measles cases in 2026?

Related contracts

PM Yes 5%Rules differK Yes 6.5%

Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.

Saved prices; check contract rules.

3 saved comparisonsNext deadline Jan 1, 2027 UTC

Market Insights

Price gaps of 2 pp+

0

Same-question pairs

0

No outcomes on this page have been reviewed as the same question on both platforms yet.

Price differences do not establish arbitrage. Check each pair's review, current order prices, fees and settlement rules.

Trade This Market